# US 2026/0090753 A1 · System and Apparatus for Wearable Hemodynamic Monitoring

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0090753 A1
- Document ID: US20260090753A1
- Status: Published application
- Kind: A1
- Application number: 19/315,900
- Filed: 2025-09-02
- Published: 2026-04-02
- Earliest claimed: 2024-09-02
- Assignees: Hemodynamiq Wearables Private (Pvt) Limited (Ltd)
- Applicants: Hemodynamiq Wearables Private (Pvt) Limited (Ltd)
- Inventors: Deepanjan DATTA; Sai Kamalesh RAYAPROLU
- Web page: https://patentgrep.com/patent/US20260090753A1

## CPC

- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/282: Holders for multiple electrodes (for introduction into the body A61B5/287)
- A61B 5/0006: {ECG or EEG signals}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/0535: Impedance plethysmography (for measuring blood flow A61B5/0295)
- A61B 5/256: Wearable electrodes, e.g. having straps or bands
- A61B 5/257: using adhesive means, e.g. adhesive pads or tapes
- A61B 5/265: containing silver or silver chloride
- A61B 5/28: for electrocardiography [ECG]
- A61B 5/308: for electrocardiography [ECG]
- A61B 5/366: Detecting abnormal QRS complex, e.g. widening
- A61B 5/6823: {Trunk, e.g., chest, back, abdomen, hip}
- A61B 5/6833: {Adhesive patches}
- A61B 5/725: {using specific filters therefor, e.g. Kalman or adaptive filters (specific diagnostics methods using using bioelectric or biomagnetic signals A61B5/316)}
- A61B 5/7264: {Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 2560/0228: using calibration standards
- A61B 2562/0215: Silver or silver chloride containing
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61B 2562/166: the sensor is mounted on a specially adapted printed circuit board
- A61B 2562/227: Sensors with electrical connectors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A wearable, non-invasive, and non-intrusive hemodynamic monitoring device is disclosed for continuous monitoring of left ventricular (LV) hemodynamic waveforms and associated cardiovascular parameters. The device includes a flexible body with laterally extending electrode wings and a central rigid housing containing signal acquisition and transmission electronics. In various embodiments, the device includes either two or three wings configured for placement along the midsternal region and over the carotid arteries to enable simultaneous acquisition of electrical and mechanical signals via bioimpedance, ECG/EKG, and accelerometer sensors. Each wing incorporates tetrapolar bioimpedance electrode arrays, current injection electrodes, voltage sensing electrodes, and accelerometers to capture thoracic and cervical physiological signals necessary for estimating parameters such as left ventricular end diastolic pressure, extracellular fluid, left ventricular ejection fraction, cardiac out, stroke volume and QRS measures. The sensor signals are routed through flexible interconnects or magnetic mating connectors to the central housing. The system includes a wireless transmitter module supporting Bluetooth, Wi-Fi, or other wireless standards, a power supply and power management circuitry, and is constructed on ultra-thin, stretchable substrates composed of biocompatible flexible polymers. The modular design also includes user-serviceable magnetic connectors and optional adhesive layers for improved skin contact, thereby enabling continuous, real-time cardiovascular monitoring suitable for ambulatory and remote healthcare environments.

## Claims

### Claim 1

A wearable hemodynamic monitoring device for monitoring left ventricular (LV) parameters of a subject comprising:
a rigid housing with a signal acquisition unit (SAU), the SAU is configured with a data transmission module and a processing module;
a flexible body which includes bioimpedance and ECG/EKG electrodes and accelerometer sensors configured to acquire raw bioimpedance, EKG/ECG and acceleration waveforms from a midsternal region and a common carotid artery region of a subject wearing the hemodynamic monitoring device, the flexible body is connected to the rigid housing and are in electrical communication with the SAU;
wherein the processing module of the SAU preprocesses the raw bioimpedance, EKG/ECG and acceleration waveforms acquired from the subject to produce preprocessed bioimpedance, EKG/ECG and acceleration waveforms;
wherein the data transmission module transmits the preprocessed biopedance, EKG/ECG and acceleration waveforms to a backend system for analysis; and
wherein the wearable hemodynamic monitoring device facilitates predicting heart failure based on multiple simultaneous congestion phenotypes.

### Claim 2 (depends on 1)

The wearable hemodynamic monitoring device of claim 1, wherein:
the flexible body comprises elongated flexible wings with the bioimpedance and EKG/ECG electrodes; and
the elongated flexible wings extend from the rigid housing.

### Claim 3 (depends on 2)

The wearable hemodynamic monitoring device of claim 2, wherein the elongated flexible wings are configured to be connectable to and detachable from the rigid housing.

### Claim 4 (depends on 2)

The wearable hemodynamic monitoring device of claim 2, wherein the flexible body comprises first and second elongated flexible wings, wherein:
the first wing is configured to position the bioimpedance and EKG/ECG electrodes of the first wing along the midsternal of the subject;
the second wing is configured to position the bioimpedance and EKG/ECG electrodes along a side of the subject's neck over a common carotid artery of the side.

### Claim 5 (depends on 4)

The wearable hemodynamic monitoring device of claim 4, wherein the one side of the subject's neck is the right side of the subject's neck over a right common carotid artery overlying the sternocleidomastoid muscles.

### Claim 6 (depends on 4)

The wearable hemodynamic monitoring device of claim 4, wherein
the first wing further comprises a first accelerometer sensor; and
the second wing further comprises a second accelerometer sensor.

### Claim 7 (depends on 2)

The wearable hemodynamic monitoring device of claim 2, wherein the flexible body comprises first, second and third elongated flexible wings, wherein:
the first wing is configured to position the bioimpedance and EKG/ECG electrodes of the first wing along a midsternal of a subject;
the second wing is configured to position the bioimpedance and EKG/ECG electrodes along a right side of the subject's neck on a right common carotid artery overlying the sternocleidomastoid muscles; and
the third wing is configured to position the bioimpedance and EKG/ECG electrodes along a left side of the subject's neck on a left common carotid artery overlying the sternocleidomastoid muscles.

### Claim 8 (depends on 7)

The wearable hemodynamic monitoring device of claim 7, wherein
the first wing further comprises a first accelerometer sensor;
the second wing further comprises a second accelerometer sensor; and
the third wing further comprises a third accelerometer sensor.

### Claim 9 (depends on 2)

The wearable hemodynamic monitoring device of claim 2, wherein the flexible body comprises:
an array of rows and columns of bioimpedance electrodes; and
EKG/ECG electrodes and accelerometer sensor disposed within rows of the array of bioimpedance electrodes.

### Claim 10 (depends on 9)

The wearable hemodynamic monitoring device of claim 9, wherein the flexible body comprises a rectangular-shaped body disposed on a subject's chest around the aorta.
